NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-113-2011-0-PCT-02 WIRELESSLY POWERED MRI SIGNAL AMPLIFICATION SYSTEM AND METHOD PCT PCT PCT/US12/031083 Expired
NCATS E-144-2012-1-US-01 Salicylic Acid Derivatives And Additional Compounds Useful As Glucocerebrosidase Activators US 61/616,773 Abandoned
NCI E-217-2011-1-US-01 A NOVEL INTERFERON-ANALOG (IFNAN) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF US 61/616,664 Abandoned
CC E-541-2013-0-US-01 QUANTITATIVE PERFUSION ANALYSIS FOR EMBOLOTHERAPY US 61/616,926 Abandoned
NCATS E-144-2012-0-US-01 Salicylic Acid Derivatives Useful As Glucocerebrosidase Activators US 61/616,758 Abandoned
NCI E-135-2012-0-US-01 DNA METHYLATION ANALYSIS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF ADRENAL NEOPLASMS US 61/615,869 Abandoned
NCI E-264-2011-0-US-01 Novel Delivery Of Packaged RNA In Mammalian Cells US 61/615,687 Abandoned
NIAID E-242-2011-0-GB-09 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing GB EP 12782672.5 Issued
NIAID E-242-2011-0-EP-04 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing EP National Stage 12782672.5 Issued
NIAID E-242-2011-0-DE-07 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing DE EP 12782672.5 Issued
NIAID E-242-2011-0-FR-08 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing FR EP 12782672.5 Issued
NIAID E-242-2011-0-CA-03 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing CA National Stage 2835522 Issued
NIAID E-300-2009-5-US-07 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US National Stage 13/498,125 9175070 Issued PDF
NIAID E-300-2009-5-US-09 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US ORD 13/429,286 8637036 Issued PDF
NIAID E-242-2011-0-PCT-02 Isolation Of Novel Broadly Neutralizing Monoclonal Antibodies Against HIV-1 Using Epitope-specific Glycoprotein Probes To Identify HIV-1 Specific B-cells PCT PCT PCT/US2012/030436 Expired
NIAID E-300-2009-7-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE US CIP 13/429,279 Abandoned
NIAID E-213-2011-1-PCT-01 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE PCT PCT COMB PCT/US2012/030465 Expired
NCI E-078-2012-0-US-01 Anti-Mesothelin Chimeric Antigen Receptors US 61/614,612 Abandoned
NCATS E-188-2009-2-US-02 Aminothienopyridazine Inhibitors of TAU Assembly US National Stage 13/497,697 Abandoned
NIA E-084-2011-0-CA-06 Compositions and Methods for Enhancing the Pluripotency of Stem Cells CA National Stage 2830600 Issued
NCI E-148-2011-0-CA-04 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CA National Stage 2832540 Issued
NCI E-148-2011-0-CZ-21 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CZ EP 12710856.1 Issued
NCI E-148-2011-0-AT-18 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AT EP 12710856.1 Issued
NCI E-148-2011-0-BE-19 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer BE EP 12710856.1 Issued
NCI E-148-2011-0-FR-24 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer FR EP 12710856.1 Issued
NCI E-148-2011-0-DE-22 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer DE EP 12710856.1 Issued
NCI E-148-2011-0-EP-06 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer EP National Stage 12710856.1 Issued
NCI E-148-2011-0-GR-26 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer GR EP 12710856.1 Issued
NCI E-148-2011-0-IT-28 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IT EP 12710856.1 Issued
NCI E-148-2011-0-IE-27 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IE EP 12710856.1 Issued
NCI E-148-2011-0-NL-29 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer NL EP 12710856.1 Issued
NCI E-148-2011-0-GB-25 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer GB EP 12710856.1 Issued
NCI E-148-2011-0-TR-36 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer TR EP 12710856.1 Issued
NCI E-148-2011-0-CH-20 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CH EP 12710856.1 Issued
NCI E-148-2011-0-ES-23 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer ES EP 12710856.1 Issued
NCI E-148-2011-0-SE-33 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SE EP 12710856.1 Issued
NCI E-148-2011-0-NO-30 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer NO EP 12710856.1 Issued
NCI E-148-2011-0-SI-34 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SI EP 12710856.1 Issued
NCI E-148-2011-0-SK-35 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer SK EP 12710856.1 Issued
NCI E-148-2011-0-PL-31 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PL EP 12710856.1 Issued
NCI E-148-2011-0-PT-32 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PT EP 12710856.1 Issued
NIA E-084-2011-0-EP-05 Compositions and Methods for Enhancing the Pluripotency of Stem Cells EP National Stage 12760251.4 Issued
NIA E-084-2011-0-AU-03 Compositions and Methods for Enhancing the Pluripotency of Stem Cells AU National Stage 2012230894 Issued
NCI E-148-2011-0-AU-03 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AU National Stage 2012240562 Issued
NCI E-014-2000-0-US-05 Methods of Use of Fragments of Secreted Frizzled Related Protein, sFRP US DIV 13/426,520 8735355 Expired PDF
NCI E-148-2011-0-PCT-02 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PCT PCT PCT/US12/29861 Abandoned
NCI E-205-2009-0-JP-05 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP National Stage 532100/2012 Abandoned
NIAID E-023-2003-0-AU-11 MVA Expressing Modified HIV Envelope, GAG, and POL Genes AU DIV 2012201689 Abandoned
NINDS E-025-2013-0-US-01 OASIS: Automated Brain Lesion Detection Using Cross Sectional Multimodality Magnetic Resonance Imaging US 61/613,569 Abandoned
NIA E-084-2011-0-PCT-02 Compositions and Methods for Enhancing the Pluripotency of Stem Cells PCT PCT PCT/US12/030005 Expired